Systematic reviews and meta-analyses report modest improvements in fasting glucose, insulin sensitivity, lipid markers, and blood pressure in some populations, particularly at doses between 24g per day.8 32 33 34 Overall, the magnitude of these effects tends to be modest.7 12 40 People with polycystic ovary syndrome (PCOS) Many of inositols studied benefits in PCOS appear to stem from its effects on insulin signaling, which plays a central role in the conditions metabolic and reproductive features
Kokrashvili Z, Mosinger B, Margolskee RF
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1
Alcohol 1999
The study concluded that GHRP-6 is a potent synthetic GH secretagogue that stimulates GH release from the pituitary gland and will be studied further in clinical settings about GH deficiency, abdominal obesity, and cachexia in subjects in the future
1 Background: metabolic-reproductive challenges of PCOS across lifespan 1.1 Epidemiology and reproductive impact Polycystic Ovary Syndrome (PCOS) is recognized not only as a reproductive disorder in women of childbearing age but also as a complex, lifelong cardiometabolic risk state ( Due to oligo-ovulation or amenorrhea, PCOS leads to a decline in natural conception rates ( This risk, superimposed with delayed childbearing, amplifies reproductive uncertainty